P2X7 is involved in the anti-inflammation effects of levobupivacaine

Ya Hsien Huang, Jiin Cherng Yen, Jie Jen Lee, Jyh Fei Liao, Wen Jinn Liaw, Chun Jen Huang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: We sough to elucidate whether purinergic P2X7 receptor is actively involved in the effects of levobupivacaine on inhibiting microglia activation. Materials and methods: Microglia were treated with lipopolysaccharide (LPS, 50 ng/mL), LPS plus levobupivacaine (50 μM), or LPS plus levobupivacaine plus the P2X7 receptor agonist Bz-ATP (100 μM) and denoted as the LPS, LPS + Levo, and LPS + Levo + Bz-ATP group, respectively. Microglia activation was measured by assaying inflammatory molecules expression. Microglia activation was also measured by assaying neuronal cell viability using coculture of microglia and neurons, as activated microglia may cause neuron injury. We also measured the levels of P2X7 receptor activation in microglia using ethidium uptake assay. Results: Our data confirmed the effects of levobupivacaine on inhibiting inflammatory molecules upregulation in activated microglia, as the concentrations of interleukin (IL)-1β, tumor necrosis factor α, IL-6, and macrophage inflammatory protein 2, of the LPS + Levo group were significantly lower than those of the LPS group (all P < 0.05). Moreover, Bz-ATP significantly abrogated the inhibitory effects of levobupivacaine, as concentrations of IL-1β, tumor necrosis factor α, IL-6, and macrophage inflammatory protein 2 of the LPS + Levo + Bz-ATP group were significantly higher than those of the LPS + Levo group (all P < 0.05). In contrast, neuronal cell viability of the LPS + Levo group was significantly higher than those of the LPS and LPS + Levo + Bz-ATP groups (P = 0.012 and 0.002). Moreover, levels of P2X7 receptor activation of the LPS and LPS + Levo + Bz-ATP groups were significantly higher than that of the LPS + Levo group (P = 0.003 and 0.006). Conclusions: P2X7 receptor is involved in the effects of levobupivacaine on inhibiting microglial activation.

Original languageEnglish
Pages (from-to)407-414
Number of pages8
JournalJournal of Surgical Research
Volume193
Issue number1
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Microglia
Purinergic P2X7 Receptors
Inflammation
Chemokine CXCL2
Interleukin-1
Interleukin-6
Cell Survival
Tumor Necrosis Factor-alpha
Neurons
Ethidium
levobupivacaine
Coculture Techniques
Lipopolysaccharides
3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate
Up-Regulation
Wounds and Injuries

Keywords

  • Cell viability
  • Levobupivacaine
  • Microglia
  • Purinergic P2X7 receptor

ASJC Scopus subject areas

  • Surgery

Cite this

P2X7 is involved in the anti-inflammation effects of levobupivacaine. / Huang, Ya Hsien; Yen, Jiin Cherng; Lee, Jie Jen; Liao, Jyh Fei; Liaw, Wen Jinn; Huang, Chun Jen.

In: Journal of Surgical Research, Vol. 193, No. 1, 2015, p. 407-414.

Research output: Contribution to journalArticle

Huang, Ya Hsien ; Yen, Jiin Cherng ; Lee, Jie Jen ; Liao, Jyh Fei ; Liaw, Wen Jinn ; Huang, Chun Jen. / P2X7 is involved in the anti-inflammation effects of levobupivacaine. In: Journal of Surgical Research. 2015 ; Vol. 193, No. 1. pp. 407-414.
@article{eb6cab28c9c94d8583e20420745ea5bf,
title = "P2X7 is involved in the anti-inflammation effects of levobupivacaine",
abstract = "Background: We sough to elucidate whether purinergic P2X7 receptor is actively involved in the effects of levobupivacaine on inhibiting microglia activation. Materials and methods: Microglia were treated with lipopolysaccharide (LPS, 50 ng/mL), LPS plus levobupivacaine (50 μM), or LPS plus levobupivacaine plus the P2X7 receptor agonist Bz-ATP (100 μM) and denoted as the LPS, LPS + Levo, and LPS + Levo + Bz-ATP group, respectively. Microglia activation was measured by assaying inflammatory molecules expression. Microglia activation was also measured by assaying neuronal cell viability using coculture of microglia and neurons, as activated microglia may cause neuron injury. We also measured the levels of P2X7 receptor activation in microglia using ethidium uptake assay. Results: Our data confirmed the effects of levobupivacaine on inhibiting inflammatory molecules upregulation in activated microglia, as the concentrations of interleukin (IL)-1β, tumor necrosis factor α, IL-6, and macrophage inflammatory protein 2, of the LPS + Levo group were significantly lower than those of the LPS group (all P < 0.05). Moreover, Bz-ATP significantly abrogated the inhibitory effects of levobupivacaine, as concentrations of IL-1β, tumor necrosis factor α, IL-6, and macrophage inflammatory protein 2 of the LPS + Levo + Bz-ATP group were significantly higher than those of the LPS + Levo group (all P < 0.05). In contrast, neuronal cell viability of the LPS + Levo group was significantly higher than those of the LPS and LPS + Levo + Bz-ATP groups (P = 0.012 and 0.002). Moreover, levels of P2X7 receptor activation of the LPS and LPS + Levo + Bz-ATP groups were significantly higher than that of the LPS + Levo group (P = 0.003 and 0.006). Conclusions: P2X7 receptor is involved in the effects of levobupivacaine on inhibiting microglial activation.",
keywords = "Cell viability, Levobupivacaine, Microglia, Purinergic P2X7 receptor",
author = "Huang, {Ya Hsien} and Yen, {Jiin Cherng} and Lee, {Jie Jen} and Liao, {Jyh Fei} and Liaw, {Wen Jinn} and Huang, {Chun Jen}",
year = "2015",
doi = "10.1016/j.jss.2014.07.020",
language = "English",
volume = "193",
pages = "407--414",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - P2X7 is involved in the anti-inflammation effects of levobupivacaine

AU - Huang, Ya Hsien

AU - Yen, Jiin Cherng

AU - Lee, Jie Jen

AU - Liao, Jyh Fei

AU - Liaw, Wen Jinn

AU - Huang, Chun Jen

PY - 2015

Y1 - 2015

N2 - Background: We sough to elucidate whether purinergic P2X7 receptor is actively involved in the effects of levobupivacaine on inhibiting microglia activation. Materials and methods: Microglia were treated with lipopolysaccharide (LPS, 50 ng/mL), LPS plus levobupivacaine (50 μM), or LPS plus levobupivacaine plus the P2X7 receptor agonist Bz-ATP (100 μM) and denoted as the LPS, LPS + Levo, and LPS + Levo + Bz-ATP group, respectively. Microglia activation was measured by assaying inflammatory molecules expression. Microglia activation was also measured by assaying neuronal cell viability using coculture of microglia and neurons, as activated microglia may cause neuron injury. We also measured the levels of P2X7 receptor activation in microglia using ethidium uptake assay. Results: Our data confirmed the effects of levobupivacaine on inhibiting inflammatory molecules upregulation in activated microglia, as the concentrations of interleukin (IL)-1β, tumor necrosis factor α, IL-6, and macrophage inflammatory protein 2, of the LPS + Levo group were significantly lower than those of the LPS group (all P < 0.05). Moreover, Bz-ATP significantly abrogated the inhibitory effects of levobupivacaine, as concentrations of IL-1β, tumor necrosis factor α, IL-6, and macrophage inflammatory protein 2 of the LPS + Levo + Bz-ATP group were significantly higher than those of the LPS + Levo group (all P < 0.05). In contrast, neuronal cell viability of the LPS + Levo group was significantly higher than those of the LPS and LPS + Levo + Bz-ATP groups (P = 0.012 and 0.002). Moreover, levels of P2X7 receptor activation of the LPS and LPS + Levo + Bz-ATP groups were significantly higher than that of the LPS + Levo group (P = 0.003 and 0.006). Conclusions: P2X7 receptor is involved in the effects of levobupivacaine on inhibiting microglial activation.

AB - Background: We sough to elucidate whether purinergic P2X7 receptor is actively involved in the effects of levobupivacaine on inhibiting microglia activation. Materials and methods: Microglia were treated with lipopolysaccharide (LPS, 50 ng/mL), LPS plus levobupivacaine (50 μM), or LPS plus levobupivacaine plus the P2X7 receptor agonist Bz-ATP (100 μM) and denoted as the LPS, LPS + Levo, and LPS + Levo + Bz-ATP group, respectively. Microglia activation was measured by assaying inflammatory molecules expression. Microglia activation was also measured by assaying neuronal cell viability using coculture of microglia and neurons, as activated microglia may cause neuron injury. We also measured the levels of P2X7 receptor activation in microglia using ethidium uptake assay. Results: Our data confirmed the effects of levobupivacaine on inhibiting inflammatory molecules upregulation in activated microglia, as the concentrations of interleukin (IL)-1β, tumor necrosis factor α, IL-6, and macrophage inflammatory protein 2, of the LPS + Levo group were significantly lower than those of the LPS group (all P < 0.05). Moreover, Bz-ATP significantly abrogated the inhibitory effects of levobupivacaine, as concentrations of IL-1β, tumor necrosis factor α, IL-6, and macrophage inflammatory protein 2 of the LPS + Levo + Bz-ATP group were significantly higher than those of the LPS + Levo group (all P < 0.05). In contrast, neuronal cell viability of the LPS + Levo group was significantly higher than those of the LPS and LPS + Levo + Bz-ATP groups (P = 0.012 and 0.002). Moreover, levels of P2X7 receptor activation of the LPS and LPS + Levo + Bz-ATP groups were significantly higher than that of the LPS + Levo group (P = 0.003 and 0.006). Conclusions: P2X7 receptor is involved in the effects of levobupivacaine on inhibiting microglial activation.

KW - Cell viability

KW - Levobupivacaine

KW - Microglia

KW - Purinergic P2X7 receptor

UR - http://www.scopus.com/inward/record.url?scp=84925026102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925026102&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2014.07.020

DO - 10.1016/j.jss.2014.07.020

M3 - Article

VL - 193

SP - 407

EP - 414

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -